Search research articles
Contact Us
Filters
Showing results (271-280 of 499) with videos related to
Page
of 50
Sort By:
The Oncologist
|
July 21, 2021
Toward a Treatment Sequencing Strategy: A Systematic Review of Treatment Regimens in Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
Daniel V Catenacci, Joseph Chao, Kei Muro, et al.
The Lancet. Gastroenterology & Hepatology
|
May 19, 2026
Management of colorectal cancer in older adults: an expert panel recommendation to guide daily clinical practice
Gabor Liposits, Thierry André, Thomas Aparicio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2008
Clinical usefulness of EGFR gene copy number as a predictive marker in colorectal cancer patients treated with cetuximab: a fluorescent in situ hybridization study
Nicola Personeni, Steffen Fieuws, Hubert Piessevaux, et al.
The Lancet. Oncology
|
June 17, 2023
Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 study
Eric Van Cutsem, Maria di Bartolomeo, Elizabeth Smyth, et al.
Critical Reviews in Oncology/Hematology
|
May 8, 2017
Systematic review and meta-analysis of local resection or transanal endoscopic microsurgery versus radical resection in stage i rectal cancer: A real standard?
Geneviève Veereman, Joan Vlayen, Jo Robays, et al.
Journal of Geriatric Oncology
|
June 30, 2026
Management of older adults with colorectal cancer - The state-of-the-art in 2026
Gabor Liposits, Thierry André, Thomas Aparicio, et al.
The Journal of Clinical Investigation
|
August 3, 2007
Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia
Wouter M Tiel Groenestege, Stéphanie Thébault, Jenny van der Wijst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2020
Geographic and Ethnic Heterogeneity of Germline <i>BRCA1</i> or <i>BRCA2</i> Mutation Prevalence Among Patients With Metastatic Pancreatic Cancer Screened for Entry Into the POLO Trial
Talia Golan, Hedy L Kindler, Joon Oh Park, et al.
Lancet (London, England)
|
August 24, 2010
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang, Eric Van Cutsem, Andrea Feyereislova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2009
Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial
Arnaud D Roth, Sabine Tejpar, Mauro Delorenzi, et al.
Page
of 50
Search research articles
Search
Showing results (271-280 of 499) with videos related to
Sort By:
Page
of 50
The Oncologist
|
July 21, 2021
Toward a Treatment Sequencing Strategy: A Systematic Review of Treatment Regimens in Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
Daniel V Catenacci, Joseph Chao, Kei Muro, et al.
The Lancet. Gastroenterology & Hepatology
|
May 19, 2026
Management of colorectal cancer in older adults: an expert panel recommendation to guide daily clinical practice
Gabor Liposits, Thierry André, Thomas Aparicio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2008
Clinical usefulness of EGFR gene copy number as a predictive marker in colorectal cancer patients treated with cetuximab: a fluorescent in situ hybridization study
Nicola Personeni, Steffen Fieuws, Hubert Piessevaux, et al.
The Lancet. Oncology
|
June 17, 2023
Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 study
Eric Van Cutsem, Maria di Bartolomeo, Elizabeth Smyth, et al.
Critical Reviews in Oncology/Hematology
|
May 8, 2017
Systematic review and meta-analysis of local resection or transanal endoscopic microsurgery versus radical resection in stage i rectal cancer: A real standard?
Geneviève Veereman, Joan Vlayen, Jo Robays, et al.
Journal of Geriatric Oncology
|
June 30, 2026
Management of older adults with colorectal cancer - The state-of-the-art in 2026
Gabor Liposits, Thierry André, Thomas Aparicio, et al.
The Journal of Clinical Investigation
|
August 3, 2007
Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia
Wouter M Tiel Groenestege, Stéphanie Thébault, Jenny van der Wijst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2020
Geographic and Ethnic Heterogeneity of Germline <i>BRCA1</i> or <i>BRCA2</i> Mutation Prevalence Among Patients With Metastatic Pancreatic Cancer Screened for Entry Into the POLO Trial
Talia Golan, Hedy L Kindler, Joon Oh Park, et al.
Lancet (London, England)
|
August 24, 2010
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang, Eric Van Cutsem, Andrea Feyereislova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2009
Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial
Arnaud D Roth, Sabine Tejpar, Mauro Delorenzi, et al.
Page
of 50